New lipid interaction partners stimulate the inhibition of activated protein C by cell-penetrating protein C inhibitor

Summary

Protein C inhibitor (PCI, SerpinA5) is a heparin-binding serpin which can penetrate through cellular membranes. Selected negatively charged phospholipids like unsaturated phosphatidylserine and oxidised phosphatidylethanolamine bind to PCI and stimulate its inhibitory activity towards different proteases. The interaction of phospholipids with PCI might also alter the lipid distribution pattern of blood cells and influence the remodelling of cellular membranes. Here we showed that PCI is an additional binding partner of phosphatidic acid (PA), cardiolipin (CL), and phosphoinositides (PIPs). Protein lipid overlay assays exhibited a unique binding pattern of PCI towards different lipid species. In addition PA, CL, and unsaturated, monophosphorylated PIPs stimulated the inhibitory property of PCI towards activated protein C in a heparin like manner. As shown for kallistatin (SerpinA4) and vaspin (SerpinA12), the incubation of cells with PCI led to the activation of protein kinase B (AKT), which could be achieved through direct interaction of PCI with PIPs. This model is supported by the fact that PCI stimulated the PIP-dependent 5-phosphatase SHIP2 in vitro, which would result in AKT activation. Hence the interaction of PCI with different lipids might not only stimulate the inhibition of potential target protease by PCI, but could also alter intracellular lipid signalling.

Keywords

Protease inhibitors - phospholipids - coagulation factors - signal transduction - SERPINs

• References

• 1 Laurell M, Christensson A, Abrahamsson PA. et al. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-1101.
• 2 Geiger M. Protein C inhibitor, a serpin with functions in- and outside vascular biology. Thromb Haemost 2007; 97: 343-347.
• 3 Suzuki K. The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis. J Thromb Haemost 2008; 6: 2017-2026.
• 4 Huntington JA, Li W. Structural insights into the multiple functions of protein C inhibitor. Cell Mol Life Sci 2009; 66: 113-121.
• 5 Meijers JC, Herwald H. Protein C inhibitor. Semin Thromb Hemost 2011; 37: 349-354.
• 6 Müller J, Isermann B, Ducker C. et al. An exosite-specific ssDNA aptamer inhibits the anticoagulant functions of activated protein C and enhances inhibition by protein C inhibitor. Chem Biol 2009; 16: 442-451.
• 7 Jerabek I, Zechmeister-Machhart M, Binder BR. et al. Binding of retinoic acid by the inhibitory serpin protein C inhibitor. Eur J Biochem 2001; 268: 5989-5996.
• 8 Malleier JM, Oskolkova O, Bochkov V. et al. Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. Blood 2007; 109: 4769-4776.
• 9 Nishioka J, Ning M, Hayashi T. et al. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles. J Biol Chem 1998; 273: 11281-11287.
• 10 Khan MS, Singh P, Azhar A. et al. Serpin Inhibition Mechanism: A Delicate Balance between Native Metastable State and Polymerisation. J Amino Acids 2011; 2011: 606797.
• 11 Baumgärtner P, Geiger M, Zieseniss S. et al. Phosphatidylethanolamine critically supports internalisation of cell-penetrating protein C inhibitor. J Cell Biol 2007; 179: 793-804.
• 12 Shen B, Gao L, Hsu YT. et al. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. Am J Physiol Heart Circ Physiol 2010; 299: H1419-1427.
• 13 Jung CH, Lee WJ, Hwang JY. et al. Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-ki-nase/Akt pathway. Biochem Biophys Res Commun 2011; 413: 264-269.
• 14 Engelmann B, Wiedmann MK. Cellular phospholipid uptake: flexible paths to coregulate the functions of intracellular lipids. Biochim Biophys Acta 2010; 1801: 609-616.
• 15 Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006; 443: 651-657.
• 16 Sasaki T, Takasuga S, Sasaki J. et al. Mammalian phosphoinositide kinases and phosphatases. Prog Lipid Res 2009; 48: 307-343.
• 17 Vanhaesebroeck B, Leevers SJ, Ahmadi K. et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001; 70: 535-602.
• 18 Liu Y, Bankaitis VA. Phosphoinositide phosphatases in cell biology and disease. Prog Lipid Res 2010; 49: 201-217.
• 19 Bunney TD, Katan M. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer 2010; 10: 342-352.
• 20 Ooms LM, Horan KA, Rahman P. et al. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 2009; 419: 29-49.
• 21 Suwa A, Kurama T, Shimokawa T. SHIP2 and its involvement in various diseases. Expert Opin Ther Targets 2010; 14: 727-737.
• 22 Pesesse X, Deleu S, De Smedt F. et al. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 1997; 239: 697-700.
• 23 Sleeman MW, Wortley KE, Lai KM. et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med 2005; 11: 199-205.
• 24 Rehault SM, Zechmeister-Machhart M, Fortenberry YM. et al. Characterisation of recombinant human protein C inhibitor expressed in Escherichia coli. Bio-chim Biophys Acta 2005; 1748: 57-65.
• 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
• 26 Paternotte N, Zhang J, Vandenbroere I. et al. SHIP2 interaction with the cytos- keletal protein Vinexin. FEBS J 2005; 272: 6052-6066.
• 27 Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
• 28 Huntington JA. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost 2003; 1: 1535-1549.
• 29 Li W, Huntington JA. The heparin binding site of protein C inhibitor is pro- tease-dependent. J Biol Chem 2008; 283: 36039-36045.
• 30 Navarro-Fernández J, Pérez-Sánchez H, Martínez-Martínez I. et al. In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity. J Med Chem 2012; 55: 6403-6412.
• 31 Campbell RB, Liu F, Ross AH. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2003; 278: 33617-33620.
• 32 Lee EN, Lee SY, Lee D. et al. Lipid interaction of alpha-synuclein during the metal-catalysed oxidation in the presence of Cu2+ and H2O2. J Neurochem 2003; 84: 1128-1142.
• 33 Moens PD, Bagatolli LA. Profilin binding to sub-micellar concentrations of phosphatidylinositol (4,5) bisphosphate and phosphatidylinositol (3,4,5) trisp-hosphate. Biochim Biophys Acta 2007; 1768: 439-449.
• 34 Smith RH, Powell GL. The critical micelle concentration of some physiologically important fatty acyl-coenzyme A’s as a function of chain length. Arch Biochem Biophys 1986; 244: 357-360.
• 35 Suzuki K. Protein C inhibitor. Methods Enzymol 1993; 222: 385-399.
• 36 Gupta VK, Gowda LR. Alpha-1-proteinase inhibitor is a heparin binding serpin: molecular interactions with the Lys rich cluster of helix-F domain. Biochimie 2008; 90: 749-761.
• 37 Ersdal-Badju E, Lu A, Zuo Y. et al. Identification of the antithrombin III heparin binding site. J Biol Chem 1997; 272: 19393-19400.
• 38 Catz SD, Johnson JL, Babior BM. The C2A domain of JFC1 binds to 3’-phos-phorylated phosphoinositides and directs plasma membrane association in living cells. Proc Natl Acad Sci USA 2002; 99: 11652-11657.
• 39 Johnson JL, Pacquelet S, Lane WS. et al. Akt regulates the subcellular localisation of the Rab27a-binding protein JFC1 by phosphorylation. Traffic 2005; 6: 667-681.
• 40 Santamaría M, Pardo-Saganta A, Alvarez-Asiain L. et al. Nuclear a1-Antichy-motrypsin Promotes Chromatin Condensation and Inhibits Proliferation of Human Hepatocellular Carcinoma Cells. Gastroenterology. 2013 Epub ahead of print.
• 41 Obenauer JC, Yaffe MB. Computational prediction of protein-protein interactions. Methods Mol Biol 2004; 261: 445-468.
• 42 Lemmon MA, Ferguson KM. Pleckstrin Homology Domains: Phosphoinosi-tide-regulated membrane tethers. In: Biology of Phosphoinositides, Frontiers in Molecular Biology. Oxford University Press; 2000: 131-165.
• 43 Onnockx S, De Schutter J, Blockmans M. et al. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners. J Cell Physiol 2008; 214: 260-272.